Seuraa
Erkka Karl Syvälahti
Erkka Karl Syvälahti
Professor, Dept. Pharmacology and Clinical Pharmacology
Vahvistettu sähköpostiosoite verkkotunnuksessa fimnet.fi
Nimike
Viittaukset
Viittaukset
Vuosi
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
T Pohjalainen, JO Rinne, K Någren, P Lehikoinen, K Anttila, ...
Molecular psychiatry 3 (3), 256-260, 1998
8441998
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, ...
Lancet (London, England) 346 (8983), 1130-1131, 1995
4301995
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence
J Hietala, C West, E Syvälahti, K Någren, P Lehikoinen, P Sonninen, ...
Psychopharmacology 116, 285-290, 1994
3361994
Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior
T Hallikainen, T Saito, HM Lachman, J Volavka, T Pohjalainen, ...
Molecular psychiatry 4 (4), 385-388, 1999
3271999
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, ...
Schizophrenia research 35 (1), 41-50, 1999
3191999
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
T Pohjalainen, JO Rinne, K Någren, E SyvÄlahti, J Hietala
American Journal of Psychiatry 155 (6), 768-773, 1998
3121998
Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism
J Tiihonen, T Hallikainen, H Lachman, T Saito, J Volavka, J Kauhanen, ...
Molecular psychiatry 4 (3), 286-289, 1999
2691999
Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography
J Hietala, E Syvälahti, K Vuorio, K Nägren, P Lehikoinen, U Ruotsalainen, ...
Archives of general psychiatry 51 (2), 116-123, 1994
2501994
Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride
JO Rinne, J Hietala, U Ruotsalainen, E Säkö, A Laihinen, K Någren, ...
Journal of Cerebral Blood Flow & Metabolism 13 (2), 310-314, 1993
2441993
Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?
V Lehtinen, J Aaltonen, T Koffert, V Räkköläinen, E Syvälahti
European psychiatry 15 (5), 312-320, 2000
2432000
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
EP Pälvimäki, H Majasuo, A Laakso, M Kuoppamäki, E Syvälahti, BL Roth, ...
Psychopharmacology 126, 234-240, 1996
2351996
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects
A Laakso, H Vilkman, J Örgen Bergman, M Haaparanta, O Solin, ...
Biological psychiatry 52 (7), 759-763, 2002
2322002
Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind …
BG Appelberg, EK Syvalahti, TE Koskinen, OP Mehtonen, TT Muhonen, ...
Journal of Clinical Psychiatry 62 (6), 448-452, 2001
2122001
The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects
A Laakso, T Pohjalainen, J Bergman, J Kajander, M Haaparanta, O Solin, ...
Pharmacogenetics and genomics 15 (6), 387-391, 2005
2112005
Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists
M Kuoppamäki, E Syvälahti, J Hietala
European Journal of Pharmacology: Molecular Pharmacology 245 (2), 179-182, 1993
1621993
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography
A Laakso, H Vilkman, B Alakare, M Haaparanta, J Bergman, O Solin, ...
American Journal of Psychiatry 157 (2), 269-271, 2000
1602000
Personality traits and striatal dopamine synthesis capacity in healthy subjects
A Laakso, E Wallius, J Kajander, J Bergman, O Eskola, O Solin, T Ilonen, ...
American Journal of Psychiatry 160 (5), 904-910, 2003
1432003
Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia
A Laakso, J Bergman, M Haaparanta, H Vilkman, O Solin, E Syvälahti, ...
Schizophrenia research 52 (1-2), 115-120, 2001
1422001
The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients
CC Joyal, MP Laakso, J Tiihonen, E Syvälahti, H Vilkman, A Laakso, ...
Biological psychiatry 54 (11), 1302-1304, 2003
1202003
Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man
S Aalto, J Ihalainen, J Hirvonen, J Kajander, H Scheinin, H Tanila, ...
Psychopharmacology 182, 375-383, 2005
1192005
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20